ESSA Pharma Inc
NASDAQ:EPIX
ESSA Pharma Inc
NASDAQ:EPIX
Price:
6.25 USD
-2.34%
Market Closed
Updated:
Apr 25, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of EPIX.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EPIX
Relative Value
Base Case
Not Available
Valuation Multiples
Multiples Across Competitors
EPIX Competitors Multiples
ESSA Pharma Inc Competitors
ESSA Pharma Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
276m USD | 0 | -10.7 | -4.2 | -4.2 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
296.3B USD | 5.5 | 61.5 | 13.3 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
146.2B USD | 5.2 | 21.8 | 16.2 | 24.3 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
103.3B USD | 10.5 | 28.5 | 22.8 | 23.9 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
99.2B USD | 7.6 | 25.1 | 16.7 | 18.3 | |
| AU |
|
CSL Ltd
ASX:CSL
|
134.5B AUD | 6.2 | 35.4 | 21.4 | 26.6 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
83.6B USD | 3.1 | 14.8 | 8.1 | 10.4 | |
| US |
|
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.8 | -57.5 | -61.9 | -55.8 | |
| US |
|
Moderna Inc
NASDAQ:MRNA
|
41.6B USD | 6.1 | -8.8 | -9.3 | -7.9 | |
| US |
|
Biogen Inc
NASDAQ:BIIB
|
29.3B USD | 3 | 25.2 | 13.8 | 17.1 | |
| KR |
|
Celltrion Inc
KRX:068270
|
37.2T KRW | 17.1 | 69.4 | 42.6 | 58.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
